4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000031
Chief Scientific Officer sold 18,980 shares at an average $15.16 ($287,695)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2024-05-16 | Sale 10b5-1 | −1,000 | $15.00 | $15,000 | 208,032 | D |
| Sethuraman Natarajan Chief Scientific Officer | 2024-05-17 | Sale 10b5-1 | −8,305 | $15.14 | $125,751 | 199,727 | D |
| Sethuraman Natarajan Chief Scientific Officer | 2024-05-20 | Sale 10b5-1 | −9,675 | $15.19 | $146,944 | 190,052 | D |
| Open-market sales · 18,980 sh · avg $15.16 · $287,695 | |||||||
Loading xslF345X05/wk-form4_1716240336.xml…